Classic Garry Hounsell.... should be a bloody comedian!
Myer is of the view and has a policy that NPAT (pre-individually significant items and implementation costs),is the most appropriate measure of its financial performance. This is the financial metric against which Myer reports and against which it assesses its financial performance, and in particular, its financial performance in the context of its continuous disclosure obligations under ASX Listing Rule 3.1.
"If ASX disagrees with this view and considers that sales and not NPAT is the most appropriate measure of a listed company’s financial performance then we would request ASX issue a guidance note to all ASX listed companies stating the same."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
-0.015(2.44%) |
Mkt cap ! $1.036B | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 62.5¢ | 60.0¢ | $16.61M | 27.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 67 | 2196860 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 39085 | 5 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MYR (ASX) Chart |